Last updated December 16, 2022
Otitis Media with Effusion
Diagnosis
1a. Pneumatic otoscopy
The clinician should document the presence of middle ear effusion with pneumatic otoscopy when diagnosing otitis media with effusion (OME) in a child. (S)
6889
Pneumatic otoscopy
The clinician should perform pneumatic otoscopy to assess for OME in a child with otalgia, hearing loss, or both. (S)
6889
Tympanometry
Clinicians should obtain tympanometry in children with suspected OME for whom the diagnosis is uncertain after performing (or attempting) pneumatic otoscopy. (S)
6889
Failed newborn hearing screen
Clinicians should document in the medical record counseling of parents of infants with OME who fail a newborn hearing screen regarding the importance of follow-up to ensure that hearing is normal when OME resolves and to exclude an underlying sensorineural hearing loss. (R)
6889
Child at-risk
Clinicians should determine if a child with OME is at increased risk for speech, language, or learning problems from middle ear effusion because of baseline sensory, physical, cognitive, or behavioral factors (Table 4). (R)
6889
Evaluating at-risk children
Clinicians should evaluate at-risk children (Table 4) for OME at the time of diagnosis of an at-risk condition and at 12-18 months of age (if diagnosed as being at-risk prior to this time). (R)
6889
Screening healthy children
Clinicians should NOT routinely screen children for OME who are not at-risk (Table 4) and do not have symptoms that may be attributable to OME, such as hearing difficulties, balance (vestibular) problems, poor school performance, behavioral problems, or ear discomfort. (R)
6889
Treatment
Patient education
Clinicians should educate families of children with OME regarding the natural history of OME, need for follow-up, and the possible sequelae. (R)
6889
Watchful waiting
Clinicians should manage the child with OME who is not at-risk with watchful waiting for 3 months from the date of effusion onset (if known) or 3 months from the date of diagnosis (if onset is unknown). (S)
6889
Steroids
Clinicians should recommend against using intranasal steroids or systemic steroids for treating OME. (S)
6889
Antibiotics
Clinicians should recommend against using systemic antibiotics for treating OME. (S)
6889
Antihistamines or decongestants
Clinicians should recommend against using antihistamines, decongestants, or both for treating OME. (S)
6889
Hearing test
Clinicians should obtain an age-appropriate hearing test if OME persists for ≥3 months OR for OME of any duration in an at-risk child. (R)
6889
Speech and language
Clinicians should counsel families of children with bilateral OME and documented hearing loss about the potential impact on speech and language development. (R)
6889
Surveillance of chronic OME
Clinicians should reevaluate, at 3- to 6-month intervals, children with chronic OME until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected. (R)
6889
Surgery for children less than 4 years old
Clinicians should recommend tympanostomy tubes when surgery is performed for OME in a child less than 4 years old; adenoidectomy should not be performed unless a distinct indication (e.g., nasal obstruction, chronic adenoiditis) exists other than OME. (R)
6889
Surgery for children 4 years old or older
Clinicians should recommend tympanostomy tubes, adenoidectomy, or both when surgery is performed for OME in a child 4 years old or older. (R)
6889
Outcome assessment
When managing a child with OME clinicians should document in the medical record resolution of OME, improved hearing, or improved quality of life. (R)
6889
Recommendations for performing tympanostomy tube insertion:
Chronic bilateral OME with hearing difficulty
Clinicians should offer bilateral tympanostomy tube insertion to children with bilateral OME for ≥3 months (chronic OME) AND documented hearing difficulties. (R)
6889
Chronic OME with symptoms
Clinicians may perform tympanostomy tube insertion in children with unilateral or bilateral OME for ≥3 months (chronic OME) AND symptoms that are likely attributable to OME that include, but are not limited to, vestibular problems, poor school performance, behavioral problems, ear discomfort, or reduced QOL. (O)
6889
Recurrent AOM with middle ear effusion (or OME)
Clinicians should offer bilateral tympanostomy tube insertion to children with recurrent AOM who have unilateral or bilateral middle ear effusion (or OME) at the time of assessment for tube candidacy. (R)
6889
Tympanostomy tubes in at-risk children
Clinicians may perform tympanostomy tube insertion in at-risk children with unilateral or bilateral OME that is unlikely to resolve quickly as reflected by a type B (flat) tympanogram or persistence of effusion for ≥3 months (chronic OME). (O)
6889
Recommendations for NOT performing tympanostomy tube insertion:
OME of short duration
Clinicians should NOT perform tympanostomy tube insertion in children with a single episode of OME of <3 months duration. (R)
6889
Recurrent AOM without middle ear effusion (or OME)
Clinicians should NOT perform tympanostomy tube insertion in children with recurrent AOM who do not have middle ear effusion (or OME) in either ear at the time of assessment for tube candidacy. (R)
6889
Title
Otitis Media with Effusion
Authoring Organization
American Academy of Otolaryngology - Head and Neck Surgery Foundation
Endorsing Organization
American Academy of Family Physicians
Publication Month/Year
February 1, 2016
External Publication Status
Published
Country of Publication
US
Document Objectives
The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing OME and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy, identify children who are most susceptible to developmental sequelae from OME, and educate clinicians and patients regarding the favorable natural history of most OME and the clinical benefits for medical therapy (eg, steroids, antihistamines, decongestants).
Target Patient Population
Children aged 2 months through 12 years with OME, with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae
Target Provider Population
All clinicians who are likely to diagnose and manage children with OME
Inclusion Criteria
Female, Male, Child
Health Care Settings
Ambulatory, Childcare center, School
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Treatment
Diseases/Conditions (MeSH)
D010034 - Otitis Media with Effusion
Keywords
otitis media, middle ear, otitis media with effusion, middle ear effusion, tympanostomy tubes, adenoidectomy, OME
Source Citation
Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology–Head and Neck Surgery. 2016;154(1_suppl):S1-S41. doi:10.1177/0194599815623467
Methodology
Number of Source Documents
212
Literature Search Start Date
January 1, 2004
Literature Search End Date
January 1, 2015